Articles On Actinogen Medical (ASX:ACW)

Title Source Codes Date
ScoPo’s Powerplays: Healthcare sector has bounced back as earnings season kicks off, expect to buy on the dips

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week Healthcare...

Stockhead ACW 4 days ago
Check Up: Rhythm (ASX:RHY) plans US expansion, the US$1.5b dog dermatitis market and data dumps drive stocks down

It’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 74 losing it and 21 flatlining. Analytica Limited (ASX:ALT) was the biggest gainer, up 25% from 8 to 20 July, followed by  Rhinomed (ASX:RNO)...

Stockhead ACW 6 days ago
Here’s why the Actinogen (ASX:ACW) share price is rocketing 13% today

The Actinogen Medical Ltd (ASX: ACW) share price is soaring today after the company announced news of its XanaMIA trial. According to the release, the first patient has been enrolled in Part A of XanaMIA’s 2-part trial. The trial targets p...

Motley Fool ACW 1 week ago
Closing Bell: Today’s biggest small cap movers on the ASX

Closing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intraday trade. WINNERS Scrol...

Stockhead ACW 2 weeks ago
Check up: A mixed bag for ASX health stocks as FDA decides fates at the flip of a coin

It’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52 losing it – and 21 flatlining. Botanix Pharma Ltd (ASX:BOT) was the biggest gainer, up 38% from 23 June to 7 July, and Suda Pharmaceuticals...

Stockhead ACW 2 weeks ago
Closing Bell: Today’s biggest small cap movers on the ASX

Closing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intraday trade.   WINNERS Scr...

Stockhead ACW 2 weeks ago
The 100 best performing ASX stocks in FY21

In FY21 the ASX 200 returned over 20 per cent but the 100 best performing ASX stocks all gained over 390 per cent and made an average gain of 821 per cent. Stockhead has compiled a list (see below) of the 100 best performing ASX stocks base...

Stockhead ACW 3 weeks ago
The surge and plunge in ASX biotech shows what the FDA giveth, the FDA taketh away

Over the past month, a number of US FDA approvals have moved the share prices of global pharma stocks, including those traded here on the ASX. The biggest FDA announcement during the month came out of US-based Biogen, which received a contr...

Stockhead ACW 4 weeks ago
ScoPo’s Powerplays: Buying opportunities in a volatile week and stock downgrades

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week Healthcare...

Stockhead ACW 1 month ago
Why Actinogen, Novonix, ResMed, & Zip shares are pushing higher

In early afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is out of form and tumbling lower. At the time of writing, the benchmark index is down 0.4% to 7,310.8 points. Four ASX shares that have not let that hold them back today are l...

Motley Fool ACW 1 month ago
10 at 10: These ASX stocks have given shareholders something to cheer about this morning

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

Stockhead ACW 1 month ago
Why the Actinogen (ASX:ACW) share price is rocketing 17% higher

The Actinogen Medical Ltd (ASX: ACW) share price has been a strong performer on Wednesday morning. At the time of writing, the shares of the biotechnology company developing an innovative treatment for cognitive impairment are up 17% to 17...

Motley Fool ACW 1 month ago
Here’s why the Actinogen Medical (ASX: ACW) share price is up 20%

Shares in Actinogen Medical Ltd (ASX: ACW) soared today after the company released news on the upcoming study of its drug designed to treat Alzheimer’s disease. At market close, the Actinogen share price was trading at 16 cents – 19.23% hi...

Motley Fool ACW 1 month ago
ASX closes 1.8% lower as Fed updates drag bank stocks

Summary The ASX 200 closed sharply lower by 133.60 points or 1.81% at 7,235.30. The market witnessed a sharp, heavy sell-off on persistent concerns over hawkish outlook by the US Federal Reserve. All four big four lenders - Westpac, C...

Kalkine Media ACW 1 month ago
Closing Bell: Today’s biggest small cap movers on the ASX

Closing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers during the trading day. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intrad...

Stockhead ACW 1 month ago
Dr Boreham’s Crucible: Is it time to make a song and dance about Actinogen (ASX:ACW)?

Whether it’s ultimately justified or not, the US Food and Drug Administration’s approval of an apparently less-than-effective drug for Alzheimer’s disease has created a ripple of excitement around the sector. This is evidenced by a mob call...

Stockhead ACW 1 month ago
ScoPo’s Powerplays: ‘Prepare for a big jump in July’ as tax-loss selling in healthcare continues

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week As we appro...

Stockhead ACW 1 month ago
As neuroscience blurs the line between tech and biology, these ASX brain health stocks are on the frontline

Recent advances in our still-shallow understanding of the human brain have led to a renewed interest in companies that focus on neuroscience. The most famous neuroscience startup, Elon Musk’s Neuralink, is probably the first company that co...

Stockhead ACW 1 month ago
Closing Bell: Today’s biggest small cap movers on the ASX

Closing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers during the trading day. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intrad...

Stockhead ACW 1 month ago
These 5 ASX shares are delivering the biggest gains in 2021

Coming up to the halfway mark of 2021, it is worth reflecting on what ASX shares have been the biggest moneymakers of the year so far. Some of these companies you might know, some you might not. But if you invested at the start of the year...

Motley Fool ACW 1 month ago
Why is the Actinogen (ASX:ACW) share price up 414% in 3 months?

The Actinogen Medical Ltd (ASX: ACW) share price has been an investor’s dream of late, rising 414% in the last 3 months and 552% over the last 12 months. With a raft of good news for the biotechnology company lately, we take a closer look....

Motley Fool ACW 1 month ago
Dr Steven Gourlay from Actinogen (ASX:ACW)

Peter Switzer sits down with the CEO and Managing Director of Actinogen Medical (ACW), Dr Steven Gourlay.

Switzer ACW 1 month ago
Hot Money…Tuesday: Bringing the heat with unique share placements and monster mining finds

Each week, Stockhead recaps ASX stocks that are “running hot” as deduced by the Relative Strength Index (RSI). The RSI is a technical gauge which measures how trading momentum is affecting the price action. A reading of 70 is seen as the le...

Stockhead ACW 1 month ago
Alzheimer’s Decision Sends Positive Message to Aussie Biotechs

ShareCafeAlzheimer’s Decision Sends Positive Message to Aussie Biotechs The US Food and Drug Administration’s landmark but controversial approval of a new treatment for Alzheimer’s disease suggests a sea change in the regulator’s attitude t...

ShareCafe ACW 1 month ago
Check Up: As Alzheimer’s grabs the spotlight, these ASX biotech stocks also impressed

Here’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has returned 2.3 per cent for the last two weeks, compared to the broader market which rose by 2.7 per cent. The biggest news globally was out of U...

Stockhead ACW 1 month ago
10 at 10: These ASX stocks are the most passionately supported this morning

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

Stockhead ACW 1 month ago
FDA’s landmark approval of Biogen’s Alzheimer’s drug sends Cogstate up 60 per cent

Cogstate (ASX:CGS) has become the latest ASX health stock to gain from an FDA green light even though it is only indirectly involved – right now. Overnight the US regulator approved the first Alzheimer’s therapy since 2003 and the first dru...

Stockhead ACW 1 month ago
ScoPo’s Powerplays: Mental health takes centre stage; Actinogen to progress Alzheimer’s study

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week It has been...

Stockhead ACW 1 month ago
Closing Bell: Today’s biggest small cap movers on the ASX

Closing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers during the trading day. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intrad...

Stockhead ACW 1 month ago
Closing Bell: Today’s biggest small cap movers on the ASX

Closing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers during the trading day. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intrad...

Stockhead ACW 1 month ago
May Winners Column: Uranium, biotechs and real estate takeover targets put in the hard yards on the ASX

Last month, the ASX finally reached its pre-pandemic high, went in circles for a couple of weeks then reached it again. What else happened in May? Well, the phase “To the moon” obtained its traditional meaning once more. While the phase has...

Stockhead ACW 1 month ago
Hot Money Monday: Resources sector restores order as Traka runs hot

Investors will be watching for updates on Traka Resources (ASX:TKL) this week, after the gold explorer ripped higher on no news to post an RSI reading of 91. Each week, Stockhead recaps ASX stocks that are “running hot” as deduced by the Re...

Stockhead ACW 1 month ago
ScoPo’s Powerplays: The immune oncology space finally gets long overdue attention

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week Healthcare...

Stockhead ACW 1 month ago
10 at 10: These ASX stocks have made the biggest launch this morning

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

Stockhead ACW 2 months ago
Closing Bell: Today’s biggest small cap movers on the ASX

Closing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intraday trade. WINNERS Scrol...

Stockhead ACW 2 months ago
April Winners Column: Resources re-takes the mantle, led by one stock that gained nearly 500pc

Google April 2021 and the first things you’ll find isn’t ASX winners but questions about COVID-19. Just another month in the pandemic, right? Well, yes and no. On one hand the vaccine race continues across the world – far slower than we’d l...

Stockhead ACW 2 months ago
Here’s why Pharmaxis (ASX:PXS) shares are trending on the ASX

Summary Pharmaxis Ltd and Charlie Teo Foundation have identified a new drug that shows promise in tackling a deadly form of brain cancer. Pharmaxis’ PXS-5505 will be a part of preclinical testing to assess its efficacy for glioblastoma...

Kalkine Media ACW 2 months ago
Capital Raisings Recap: Nearly $10 billion has already been raised in 2021

The capital raisings boom on the ASX is continuing in 2021 with nearly $10 billion raised in the first four months of the year. Across 325 deals, ASX companies have raised $9.878 billion in capital amidst IPOs, placements and rights issues....

Stockhead ACW 2 months ago
Closing Bell: Today’s biggest small cap movers on the ASX

Closing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intraday trade. WINNERS Scrol...

Stockhead ACW 3 months ago
Why is the Actinogen (ASX:ACW) share price falling 17% today?

Actinogen Medical Ltd (ASX: ACW) shares are tumbling today after the company released its quarterly activity report and strategic update this morning. At the time of writing, the Actinogen share price is sliding a whopping 17.24% to 4.8 ce...

Motley Fool ACW 3 months ago
10 at 10: Investors are closely monitoring these ASX stocks this morning

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

Stockhead ACW 3 months ago
Closing Bell: Today’s biggest small cap movers on the ASX

Closing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intraday trade. WINNERS Scrol...

Stockhead ACW 3 months ago
Actinogen (ASX:ACW) share price surges 23% today, 165% this year

Actinogen Medical Ltd (ASX: ACW) shares are rocketing higher today and have now gained 165% since the start of 2021. At the time of writing, the Actinogen share price is trading 23.26% higher for the day so far at 5.3 cents, up from just 2...

Motley Fool ACW 3 months ago
March Winners Column: Oil is FINALLY on the boil

March got off to a rough start, with ASX small caps suffering their worst week since October and the Small Ords Index falling into the red on the year. But it got better. US punters received another stimmy cheque in the mail from President...

Stockhead ACW 3 months ago
Hot Money Monday: These are the most in-demand stocks on the ASX right now

Stockhead’s Hot Money Monday analysis is based on the Relative Strength Index (RSI) — a technical gauge which measures how trading momentum is affecting the price action. A reading of 70 is seen as the level at which a company may have been...

Stockhead ACW 3 months ago
Check Up: Oneview leads healthcare sector after ‘investor awareness’ pact

Here’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks for small-cap health companies, with 58 companies gaining ground and 54 losing it. Another 16 were flat. Code Company Price % return...

Stockhead ACW 4 months ago
Bill Ketelbey from Actinogen Medical (ASX:ACW)

Actinogen Medical CEO Dr Bill Ketelbey speaks at the Switzer Small and Micro Cap Virtual Investor Day 2020.

Switzer ACW 7 months ago
Actinogen Medical (ASX:ACW) share price jumps on patent news

The Actinogen Medical Ltd (ASX: ACW) share price jumped 4.5% on open this morning, after the company announced it has filed two new patent applications to strengthen and extend its intellectual property (IP) portfolio.   What does Actinoge...

Motley Fool ACW 8 months ago
Actinogen reveals its next clinical trial plans

Actinogen (ASX:ACW) has reveals plans for two clinical trials it will conduct next year - against MCI due to Alzheimers ... Read More The post Actinogen reveals its next clinical trial plans appeared first on Stockhead.

Stockhead ACW 9 months ago
Bell Potter raising for Alzheimer's drug hopeful Actinogen

ASX-listed Actinogen Medical is in front of potential investors seeking a $10 million equity injection to fund a trial for its Alzheimer's drug. 

AFR ACW 9 months ago